SG49239A1 - Amylin and possibly insulin containing composition for the treatment of aneroxia and related states - Google Patents

Amylin and possibly insulin containing composition for the treatment of aneroxia and related states

Info

Publication number: SG49239A1
Authority: SG; Singapore
Prior art keywords: amylin; treatment; aneroxia; pct; containing composition
Prior art date: 1991-05-24

Application number

SG1996008180A

Other languages

English (en)

Inventor

Timothy J Rink

Andrew A Young

Original Assignee

Amylin Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-24

Filing date

1992-05-23

Publication date

1998-05-18

1992-05-23 Application filed by Amylin Pharmaceuticals Inc filed Critical Amylin Pharmaceuticals Inc

1998-05-18 Publication of SG49239A1 publication Critical patent/SG49239A1/en

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title abstract 4
102000036770 Islet Amyloid Polypeptide Human genes 0.000 title abstract 3
108010041872 Islet Amyloid Polypeptide Proteins 0.000 title abstract 3
102000004877 Insulin Human genes 0.000 title abstract 2
108090001061 Insulin Proteins 0.000 title abstract 2
229940125396 insulin Drugs 0.000 title abstract 2
208000022531 anorexia Diseases 0.000 abstract 1
206010061428 decreased appetite Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Hematology (AREA)
Obesity (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Emergency Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SG1996008180A 1991-05-24 1992-05-23 Amylin and possibly insulin containing composition for the treatment of aneroxia and related states SG49239A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US70499591A	1991-05-24	1991-05-24
US86250092A	1992-04-03	1992-04-03

Publications (1)

Publication Number	Publication Date
SG49239A1 true SG49239A1 (en)	1998-05-18

Family

ID=27107425

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996008180A SG49239A1 (en)	1991-05-24	1992-05-23	Amylin and possibly insulin containing composition for the treatment of aneroxia and related states

Country Status (11)

Country	Link
US (1)	US5656590A (de)
EP (1)	EP0586589B1 (de)
JP (1)	JPH06510754A (de)
AT (1)	ATE157010T1 (de)
AU (1)	AU669110B2 (de)
CA (1)	CA2109794A1 (de)
DE (1)	DE69221725T2 (de)
DK (1)	DK0586589T3 (de)
ES (1)	ES2108122T3 (de)
SG (1)	SG49239A1 (de)
WO (1)	WO1992020367A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU222249B1 (hu) *	1991-03-08	2003-05-28	Amylin Pharmaceuticals Inc.	Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására
AU7685894A (en) *	1993-09-07	1995-03-27	Amylin Pharmaceuticals, Inc.	Methods for regulating gastrointestinal motility
AUPM678294A0 (en) *	1994-07-13	1994-08-04	Gropep Pty Ltd	Use of insulin-like growth factor in combination with insulin
US5783556A (en) *	1996-08-13	1998-07-21	Genentech, Inc.	Formulated insulin-containing composition
US7910548B2 (en)	1997-06-06	2011-03-22	Amylin Pharmaceuticals, Inc.	Methods for treating obesity
US6621131B2 (en) *	2001-11-01	2003-09-16	Intel Corporation	Semiconductor transistor having a stressed channel
CA2509755A1 (en) *	2002-12-27	2004-07-22	Diobex, Inc.	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7655618B2 (en)	2002-12-27	2010-02-02	Diobex, Inc.	Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US20070275877A1 (en) *	2003-08-29	2007-11-29	Amylin Pharmaceuticals, Inc.	Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders
CA2647568A1 (en) *	2006-03-31	2007-10-11	Amylin Pharmaceuticals, Inc.	Amylin and amylin agonists for treating psychiatric diseases and disorders

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8514090D0 (en) *	1985-06-04	1985-07-10	Sandoz Ltd	Organic compounds
JPS61194034A (ja) *	1985-02-25	1986-08-28	Teijin Ltd	経鼻投与用粉末状組成物
US5008241A (en) *	1985-03-12	1991-04-16	Novo Nordisk A/S	Novel insulin peptides
DK119785D0 (da) *	1985-03-15	1985-03-15	Nordisk Gentofte	Insulinpraeparat
GB8709871D0 (en) *	1987-04-27	1987-06-03	Turner R C	Peptides
GB8720115D0 (en) *	1987-08-26	1987-09-30	Cooper G J S	Treatment of diabetes mellitus
DE3717370A1 (de) *	1987-05-22	1988-12-01	Hoechst Ag	Mischkristalle aus insulin und insulinderivaten, verfahren zur herstellung dieser mischkristalle, diese mischkristalle enthaltende pharmazeutische mittel und ihre verwendung zur behandlung von diabetes mellitus
US4992418A (en) *	1987-07-17	1991-02-12	Mount Sinai School Of Medicine	Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) *	1987-07-17	1991-02-12	Mount Sinai School Of Medicine	Superactive human insulin analogues
US5049547A (en) *	1988-02-11	1991-09-17	University Patents, Inc.	Composition for stimulating integumental melanocytes
GB8915712D0 (en) *	1989-07-08	1989-08-31	Macintyre Iain	Medical treatment
EP0408294B1 (de) *	1989-07-10	1995-09-20	Amylin Pharmaceuticals, Inc.	Verwendung eines Amylinantagonisten zur Herstellung eines Artzneimittels zur Behandlung von Fettsucht und essentieller Hypertonie und damit zusammenhängenden Krankheiten
US5016643A (en) *	1990-05-02	1991-05-21	Board Of Regents, The University Of Texas System	Vascular entoptoscope
US5234906A (en) *	1991-01-10	1993-08-10	Amylin Pharmaceuticals, Inc.	Hyperglycemic compositions
AU2169392A (en) *	1991-05-24	1992-12-30	Amylin Pharmaceuticals, Inc.	Insulin and amylin containing composition for the treatment of insulin deficient mammals

1992
- 1992-05-23 US US08/157,003 patent/US5656590A/en not_active Expired - Fee Related
- 1992-05-23 SG SG1996008180A patent/SG49239A1/en unknown
- 1992-05-23 AT AT92913606T patent/ATE157010T1/de not_active IP Right Cessation
- 1992-05-23 DE DE69221725T patent/DE69221725T2/de not_active Expired - Fee Related
- 1992-05-23 WO PCT/US1992/004357 patent/WO1992020367A1/en not_active Ceased
- 1992-05-23 ES ES92913606T patent/ES2108122T3/es not_active Expired - Lifetime
- 1992-05-23 CA CA002109794A patent/CA2109794A1/en not_active Abandoned
- 1992-05-23 AU AU20115/92A patent/AU669110B2/en not_active Ceased
- 1992-05-23 EP EP92913606A patent/EP0586589B1/de not_active Expired - Lifetime
- 1992-05-23 JP JP5500331A patent/JPH06510754A/ja active Pending
- 1992-05-23 DK DK92913606.7T patent/DK0586589T3/da active

Also Published As

Publication number	Publication date
EP0586589B1 (de)	1997-08-20
DE69221725D1 (de)	1997-09-25
ES2108122T3 (es)	1997-12-16
CA2109794A1 (en)	1992-11-26
DE69221725T2 (de)	1997-12-18
AU669110B2 (en)	1996-05-30
WO1992020367A1 (en)	1992-11-26
JPH06510754A (ja)	1994-12-01
EP0586589A1 (de)	1994-03-16
DK0586589T3 (da)	1997-09-22
ATE157010T1 (de)	1997-09-15
AU2011592A (en)	1992-12-30
US5656590A (en)	1997-08-12

Publication	Publication Date	Title
ATE185548T1 (de)	1999-10-15	Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
HUT74452A (en)	1996-12-30	Preparation for substitution therapy, containing at least one progestogen and at least one extrogen
BG102425A (en)	1999-06-30	(methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
WO1994027589A3 (en)	1995-01-26	Antidepressant dosage form
MX9709351A (es)	1998-02-28	Derivados de alfa-hordotionina con alto contenido de treonina.
GR3007385T3 (de)	1993-07-30
GB9408775D0 (en)	1994-06-22	Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
HUT66429A (en)	1994-11-28	Compositions for treating osteoporosis
GR3022321T3 (en)	1997-04-30	Use of il-4 to treat solid tumors
SG49239A1 (en)	1998-05-18	Amylin and possibly insulin containing composition for the treatment of aneroxia and related states
GR3029887T3 (en)	1999-07-30	Method of preparing a radioactive rhenium complex solution.
DE69316013D1 (de)	1998-02-05	Verwendung von phosphinate zur behandlung der osteoporose
IL103383A0 (en)	1993-03-15	Pharmaceutical compositions containing glutamine and methods for the use thereof
LTIP1534A (en)	1995-06-26	Medicinal preparations for prophylaxis and treating metabolic disturbance of lipoids and cholesterin
TW261532B (de)	1995-11-01
IL105475A (en)	1997-06-10	PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS
IL109866A (en)	2000-06-01	Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine(+)L-hydrogentartrate its preparation and pharmaceutical compositions containing it
TW330933B (en)	1998-05-01	Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes
AU6826887A (en)	1987-08-06	5-substituted octahydroindolizine analgesics compounds and 7-keto intermediates
TW291439B (de)	1996-11-21
GR3022935T3 (en)	1997-06-30	Product and use of it for the treatment of catabolic states comprising authentic igf-1 and hypocaloric amount of nutritients
IL129267A0 (en)	2000-02-17	Treatment of urinary incontinence and compositions for use therein
IL98200A0 (en)	1992-06-21	Pharmaceutical composition containing a derivative of substituted-l-valyl-l-prolinamide
ATE174694T1 (de)	1999-01-15	Armband- oder taschenuhr
TW217382B (de)	1993-12-11